Realdi G, Tremolada F, Alberti A, Rigoli A, Diodati G, Visconti M
Quad Sclavo Diagn. 1975 Jun;11(2):419-30.
Among the several methods employed for the detection of hepatitis B antigen (HBAg) and hepatitis B antibody (HBAb), radioimmunoassay is considered to be the most sensitive and specific. This paper describes a radioimmunoprecipitation test (RIP) for HBAg and HBAb standardized in our laboratory; it consists of a double-antibody precipitation test in a micro-titer system employing 125I-labeled HBAg. The test is compared with double immunodiffusion (ID) and with counterimmunoelectrophoresis (CEP) in the detection of HBAg and HBAb in healthy persons and in patients with acute and chronic liver disease. RIP is 20,000 times more sensitive than ID and 2,500 times than CEP when HBAg is tested, and 40,000 times more sensitive than ID and 10,000 times than CEP for the antibody detection. Moreover the method is reproducible and specific for HBAg and HBAb. With this test the frequency of HBAg in healthy persons was 0% in subjects without any known contact with antigenic material, 0.80% in hospital personnel and 1.17% in high risk personnel (laboratory technicians, blood products workers, ecc.). In acute viral hepatitis the frequency of HBAg was 90% at the admittance to the hospital and 70% at the dimission, while CEP detected a frequency of 85% and 20% respectively. In chronic liver disease the frequency of HBAg with the RIP method was 83.3% in chronic persistent hepatitis, 42.8% in chronic aggressive hepatitis, 23% in cryptogenic cirrhosis and 16.6% in alcoholic cirrhosis. The frequency of HBAb detected with RIP was 4.50% in subjects without any known contact with antigenic material, 6.45% in hospital personnel, 0.41% in high risk personnel, 20% in acute viral hepatitis at the admittance to the hospital and 50% at the discharge, 25% in chronic persistent hepatitis, 14.2% in chronic aggressive hepatitis, 15.3% in cryptogenic cirrhosis and 50% in alcoholic cirrhosis. The high frequency of antibody in healthy persons with no history of hepatitis or parenteral exposure to blood transfusion suggests a widespread diffusion of hepatitis B infection and the possibility of a nonparenteral route transmission. The frequency of HBAg and HBAb in chronic liver disease as detected by a very sensitive method rises the question of a possible role of hepatitis B virus in the pathogenesis of the disease.
在用于检测乙型肝炎抗原(HBAg)和乙型肝炎抗体(HBAb)的几种方法中,放射免疫测定法被认为是最灵敏和特异的。本文描述了一种在我们实验室标准化的用于检测HBAg和HBAb的放射免疫沉淀试验(RIP);它是在微量滴定系统中采用125I标记的HBAg进行的双抗体沉淀试验。将该试验与双免疫扩散(ID)和对流免疫电泳(CEP)在健康人以及急慢性肝病患者中检测HBAg和HBAb的情况进行了比较。检测HBAg时,RIP比ID灵敏20000倍,比CEP灵敏2500倍;检测抗体时,RIP比ID灵敏40000倍,比CEP灵敏10000倍。此外,该方法具有可重复性,且对HBAg和HBAb具有特异性。通过该试验,在没有任何已知抗原物质接触史的健康人中HBAg的检出率为0%,医院工作人员中为0.80%,高危人员(实验室技术人员、血液制品工作人员等)中为1.17%。在急性病毒性肝炎中,入院时HBAg的检出率为90%,出院时为70%,而CEP检测到的检出率分别为85%和20%。在慢性肝病中,采用RIP方法检测HBAg的检出率在慢性持续性肝炎中为83.3%,慢性活动性肝炎中为42.8%,隐匿性肝硬化中为23%,酒精性肝硬化中为16.6%。采用RIP检测HBAb的检出率在没有任何已知抗原物质接触史的健康人中为4.50%,医院工作人员中为6.45%,高危人员中为0.41%,急性病毒性肝炎入院时为20%,出院时为50%,慢性持续性肝炎中为25%,慢性活动性肝炎中为14.2%,隐匿性肝硬化中为15.3%,酒精性肝硬化中为50%。在没有肝炎病史或非肠道输血暴露史的健康人中抗体的高检出率提示乙型肝炎感染广泛传播以及存在非肠道传播途径的可能性。通过一种非常灵敏的方法检测到的慢性肝病中HBAg和HBAb的检出率引发了乙型肝炎病毒在该疾病发病机制中可能作用的问题。